AstraZeneca Pharma India Annual General Meeting
AstraZeneca Pharma India held its 47th Annual General Meeting on August 10, 2026, where shareholders approved financial statements, dividend declaration, and key director and auditor appointments.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
AstraZeneca Pharma India held its 47th Annual General Meeting on August 10, 2026, where shareholders approved financial statements, dividend declaration, and key director and auditor appointments.
AstraZeneca Pharma India will hold its 47th Annual General Meeting on August 10, 2026, via video conferencing to transact ordinary and special business.
AstraZeneca Pharma India announced shareholders approved shifting its registered office to Maharashtra via postal ballot. The special resolution passed with a 99.99% majority vote.
AstraZeneca Pharma India Ltd has issued a postal ballot notice to shift its registered office from Karnataka to Maharashtra. The move aims to enhance administrative efficiency and strengthen the company's footprint in Mumbai. Shareholders can vote electronically from April 12 to May 11, 2026.